Cancer treatment identification and planning and its application kit

Abstract

This invention relates to a method for identifying cancer patients suitable for treatment with a compound of formula (I) and for further planning appropriate treatment for such patients, and to a kit for performing the method, the method involving detecting the performance of biomarkers in biological samples from an individual with cancer, and, based on the performance of the biomarkers, instructing the individual to use a treatment regimen comprising a compound of formula (I) and / or its pharmaceutically acceptable salts in cancer treatment, wherein T1 is a C6 cyclic hydrocarbon and R1 is a C1-C8 aliphatic hydrocarbon group.